肥胖,胰岛素抵抗和代谢综合征:白人和黑人内皮功能障碍的决定因素
1Indiana University, Indianapolis, USA.
Circulation
|June 29, 2005
概括
胰岛素抵抗和高血压是代谢综合征 (MS) 内皮功能障碍的关键驱动因素. 种族差异影响这些因素如何影响血管健康,这表明可能需要量身定制的治疗方法.
科学领域:
- 心血管科学 心血管科学
- 代谢性疾病研究研究
- 内皮功能研究 研究内皮功能研究.
背景情况:
- 胰岛素抵抗与肥胖和代谢综合征 (MS) 密切相关.
- 多发性硬化成份在内皮功能障碍中的特定作用尚未完全理解.
- 现有研究表明,与MS相关的心血管结果的种族差异存在矛盾的结果.
研究的目的:
- 调查胰岛素抵抗,肥胖和其他多发性硬化成份对内皮功能受损的贡献.
- 探索多发性硬化成份对内皮功能影响的潜在种族差异.
主要方法:
- 在白人和黑人受试者中检查了MS成分和胰岛素抵抗与内皮依赖血管扩张之间的关系.
- 经过腿部血流变化评估的内皮功能,在暴露于甲胆化物后.
- 利用多变量回归分析来确定内皮功能的独立预测因子.
主要成果:
- 黑人受试者与白人受试者相比,血管扩张减少,即使没有MS.
- 在两个族群中,多发性硬化症的存在使内皮功能恶化.
- 腰围和静脉血压最初与内皮功能障碍有关,但胰岛素抵抗成为一个关键的独立因素,取代了腰围.
结论:
- 胰岛素抵抗和静脉压是MS内皮功能障碍的主要决定因素.
- 这些因素对内皮功能的影响存在显著的种族差异.
- 这些发现表明,针对血压或胰岛素耐药性的个性化治疗策略可能对不同种族群体有益.
更多相关视频
相关概念视频
Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.


